The initial sample includes 26,553 who were not in either city ATB or were farther than 10 km from the hypocenter, and who were chosen at random from eligible subjects listed in a variety of official sources and ABCC sample censuses. In Nagasaki these sources are dated 1950, but in Hiroshima their effective dates extend from 1950 to 1953. Thus, not all 26,553 not-in-city subjects of the Life Span Study were exposed to the risk of dying throughout the first few years following 1 October 1950 as were the A-bomb survivors.
Ascertainment of Mortality
The fact of death is obtained from the family register (koseki), and the cause abstracted from the official death certificate. Koseki information on mortality has been shown to be quite complete. Migration within Japan has not thus far impaired the effectiveness of procedures for ascertaining mortality. The quality of certification of cause of death has been investigated at ABCC in special studies made possible by the high autopsy rate on sample members since 1961, and by the practical requirement that the death certificate be filed before autopsy. These studies have shown that the correspondence between the underlying cause of death coded from the death certificate, and the principal autopsy diagnosis, is generally good with respect to malignant neoplasms, and with respect to major cardiovascular-renal diseases as a class, but poor with respect to most of the individual circulatory diseases (16, 17) .
Underlying cause of death was coded from the death certificate only according to the 1955 (seventh) revision of the International Statistical Classification of Diseases, Injuries, and Causes of Death (18) as interpreted by the Statistics Division, Ministry of Health and Welfare. 3 Where pertinent, analyses of underlying causes of death (based on death certificate diagnoses) have been supplemented by analyses of autopsy diagnoses in the 1961-1966 period. In these supplementary investigations variation is sought, not between the deaths attributed to a particular cause and all other members of the sample, but within the autopsy series, in a comparison of deaths characterized by a given autopsy diagnosis (not necessarily the principal) vs. all others. The series consists of 1,576 autopsies.
Monitoring the ascertainment of mortality from the family registers has included calculation of expected deaths from the mortality rates for all Japan, with attention to age, sex, and calendar year. For the present report such calculations have been performed by Mr. M. Otake of the ABCC staff, using the 72,758 A-bomb survivors included in the initial sample, before the addition of the 9,500 reserve sub- Cause of death has been grouped as shown in Table II together with corresponding counts of deaths. These groups shape the analysis as to cause of death.
Dosimetry
Arakawa has described the general aspects of the dosimetry approach adopted at ABCC on the advice of health physicists at ORNL (5), but the particulars of his report pertain to T-57 doses. Apart from minor changes in the location of the (24) , is that the T-65 dosimetry is not commensurate for the two cities. From the T-65 curves the total air dose at 1.0 km is made up of gamma rays and neutrons in the ratio of 1.3:1 for Hiroshima, and about 25:1 for Nagasaki. In this report only the total dose in rads, gamma plus neutron, is used. Although the initial sample was stratified by distance, about 65 % of the T-65 total doses are below 10 rads, and 45 % less than one rad (7). The distribution is given in Table III by city. The four dose intervals were picked prior to analysis in an effort to avoid absurdly small expected values for high-dose classes in tables on individual causes of death. An unknown dose usually represents an unusual shielding situation within 1.6 km of the hypocenter in Hiroshima, or 2.0 km in Nagasaki, for which reliable methods of estimating attenuation do not exist (trolley cars, factories), but in some instances death or migration occurred before a shielding history could be obtained. This association between early mortality and unknown dose led to the inclusion of the unknown dose group in all T-65 dose analyses, and to the decision to parallel the dose-specific analysis with one based on distance ATB. A new grouping of distance ATB was evolved to conform to the revised airdose curves, as follows: 
Statistical and Other Considerations
All analyses have been controlled on age ATB, sex, city, and calendar time. Comparisons are either standardized for these factors or are specific for them. Socioeconomic and other factors have not been controlled. In prior reports (1-3) the mortality patterns of those who were not in the city ATB have been shown to differ from those of the A-bomb survivors in ways that seem unrelated to radiation but consistent with their status as migrants. Accordingly, chief emphasis here is placed on the search for dose-specific effects among the survivors themselves. In a sepa-rate analysis, however, A-bomb survivors have been compared with those not in the city ATB (26).
Association with radiation dose has been sought chiefly in contingency tables with dose grouped into 0-9, 10-39, 40-179, and 180+ rads, but extensive use has also been made of mean log (dose + 1) for those who lived vs. those who died of a particular cause. In the contingency table analyses there are five time periods (4 four-year intervals + total) X nine city-sex groups (2 cities X 2 sexes + subtotals and total) X about 50 causes of death. The contingency table analysis by dose was replicated by distance. Because of the biologic interest attaching to age ATB as an indicator of susceptibility to the effects of ionizing radiation, these age-standardized comparisons were supplemented with age-specific comparisons using 10-year age groups of both sexes and cities combined, but within each time period. In addition, the tests on mean log (dose + 1) were made on 10-year age groups simultaneously within city, sex, and time period, with provision for combining the tests for all age groups within a city-sex, for all four city-sex groups of a given age, for both cities for a given sex, for both sexes for a given city, and overall.
The Mantel-Haenszel method (27, 28) was used to construct contingency tables with expected values adjusted for variations in age, sex, and city. Multiple regression analyses of these tables were performed, in which the regression variables were defined in terms of dose. The estimated regression coefficients were then used to define dose-specific tests of nonhomogeneity, including tests having high power against alternatives of particular relevance, especially a linear increase in mortality with increasing dose, and a quadratic increase. The quadratic representation of a fit to the O/E ratios is fairly complex, and there is some subjectivity involved in selecting only those tests in which a suitably large x2 represents an increase with dose. In addition, those of unknown dose were compared with subjects of known dose in a separate test. Tests on the linear and quadratic alternatives used, as scale values for the four dose groups, their median values: 0, 17, 75, and 250 rads. The four distance groups were similarly represented by their corresponding median values: 0, 18, 60, and 199 rads.
The analysis was undertaken to screen the entire experience for evidence of lateeffects of radiation, not to test general models for such effects or classes of effects. The effort has been to achieve sensitivity with respect to age, sex, city, calendar time, and cause of death, insofar as the T-65 dose provides a valid measure of individual exposure. The performance of thousands of tests makes it inevitable that false positive leads will arise, against which only consistency of results and information from other sources will protect against errors of inference.
RESULTS
Observed (0) and expected (E) deaths, together with standardized mortality ratios (O/E), and estimates of relative risk (RR)4 when appropriate, are given in Table IV by T-65 total dose for major causes and groups of causes for the entire 16-year period, and for both cities and both sexes combined. The results of significance tests on these summary comparisons are also shown; a footnote gives the key to the nature of the tests abbreviated as K, L, Q and H. Both L (linear) and Q (quadratic) test for an increase in mortality with increasing dose. The presentation of results is organized by cause of death, and reference is made as needed to the more detailed analysis by age ATB, sex, city, and calendar time, and to the parallel analyses based on distance from hypocenter ATB and on mean log (dose + 1).
All Causes
Deaths from all causes (Table IV) are quite significantly elevated in relation to expectation at the higher levels of dose, and among those of unknown dose. However, this variation reflects time-and cause-specific discrepancies, not a generalized effect extending uniformly to different causes and time periods. Removal of the leukemia deaths, for example, almost eliminates the variation among dose groups, transforming the O/E ratios to 1.00, 0.98, 1.02, 1.01, and 1.07 in the sequence of Table IV. The high ratio for those of unknown dose reflects primarily a lesser availability of shielding information on deaths occurring before the ABCC shielding program was fully operational. From Table III we see that 4.6 % of all subjects lack dose estimates; this compares with 4.5 % of all deceased and 7.3 % of those dying in the 1950-1954 interval. In consequence, the O/E ratio for subjects of Table IV, where alternative Table IV. unknown dose is especially high, 1.69, in 1950-1954, and thus the T-65 dosimetry provides a less efficient tool of analysis in this period than does distance (Table V) (Table  VI) . Finally, when mortality from all causes is examined by age ATB, those under 10 ATB have the highest mortality ratios, but this is almost entirely attributable to leukemia. Thus, the excess mortality from all causes in the high dose groups, as seen in Table V, In addition to the analysis of all 853 deaths as a single class, separate analyses were performed for the 162 accidental deaths in motor vehicle accidents, the 363 deaths from other accidents, and the 299 deaths from suicide. The first two supplementary analyses (Table IV) contained no suggestion of a relation between mortality and distance or dose, but the third revealed variation that merits further study, namely, a real deficit of suicides among those who received 10-39 rads, and among those in the highest dose (and more proximal distance) groups. The deficit among those exposed to 10-39 rads derives almost entirely from Hiroshima males (5 observed vs. 19 expected). There were no suicides in the group exposed to 180+ rads until the one observed in 1962-1966, and both sexes in both cities contribute to the discrepancy. This is not just a reflection of the retrospective assignment of dose estimates, for the distance analysis gives a comparable picture: among distance group A subjects, there were 21 suicides observed vs. 28 expected, over the 16-year interval. In the parallel analyses of those who were not in the city ATB vs. the A-bomb survivors, the risk of suicide, relative to that for subjects not in the city ATB, is 0.93 among Nagasaki survivors, but 1.43 among Hiroshima survivors (P < 0.05). Whatever the causes, therefore, the nature of the discrepancy is such that the highest relative risk is seen among the A-bomb survivors exposed to the least radiation.
Natural Causes Except Leukemia (ICD # 001-203, 205-795)
The standardized mortality ratios for deaths from disease (except leukemia) vary only insignificantly in relation to dose (Table IV) Over the entire 16-year period, those who received 180+ rads died of leukemia at a rate that is about 17 times that of subjects who received less than 10 rads (Table IV) . The increased mortality among those exposed to 10-39 rads is well within the power of chance to produce. Ishimaru et al., however, employing a T-65 dose grouping of 20-49 rads, were able to show quite significant elevation of risk in those so exposed. Approximate annual death rates for the several dose groups in Table IV are four deaths/100,000/year for those exposed to 0-9 rads, 7 for those receiving 10-39 rads, 22 for those exposed to 40-179 rads, 75 for those exposed to 180+ rads, and about 17 for those of unknown dose. By comparison, the average death rate from leukemia throughout Japan in this period, for the population of comparable age, was 2-3 deaths/100,000/year, but the indications are that it was not until about 1960 that deaths from leukemia were being fully reported throughout Japan (25) . A plot of the dose-specific death rates will yield an estimated aver-age increase of about three cases of leukemia/106/year/rad for the 16-year period. However, any such average estimate ignores the difference between the cities, the bombs, and the sexes, and among the types of leukemia, the ages at exposure, and the intervals of time after the bombings.
Deaths In the 1958-1962 period there is again a significant increase in cancer mortality among Hiroshima females, but it is evident only in the distance analysis (Table X) because an exceptionally large number of such deaths occurred in women whose dose was never estimated. The O/E ratio there for Hiroshima females in distance group A represents 20 observed vs. 12 expected deaths. The other city-sex groups again fail to provide the parallel evidence that one would need to argue in favor of a carcinogenic effect with a latent period of nearly 15 years. During 1962-1966, in contrast, the evidence of all four city-sex groups combined does seem indicative of a carcinogenic effect (Table XI) . The increase in risk per 100 rads is about 20 % of expectation for the four-year period. When the 688 deaths are analyzed separately by city and sex, it is again only for Hiroshima females that the observed variation meets the criteria for statistical significance in the several tests employed, but for both Hiroshima males and Nagasaki males the trend of increasing mortality with increasing dose is similar, and for Hiroshima males the test for linear trend returns a P of 0.06 (Table XI) . When the 1962-1966 experience is examined by age ATB, the excess of observed over expected deaths is seen for almost every decade-of-birth cohort with estimated dose of 180+ rads, and for no single cohort is the O/E ratio remarkably higher than the average of 1.45. In Fig. 1 i _ bility of dying of cancer (excluding leukemia) in that interval is shown for each age cohort separately for those exposed to 0-9 rads vs. those exposed to 180+ rads. Although the numbers of deaths in the high-dose group are few in 1962-1966 (33 observed vs. 22.7 expected, and with the age-specific ratios as written out in Fig. 1) , and the curve somewhat irregular, the suggestion is strong that heavily exposed survivors in all age cohorts, or all under 60 ATB, suffered some increase in the risk of dying of cancer in this period. In 1962 those 60+ ATB were 77+.
Cancer of Digestive Organs (ICD # 150-159)
About two-thirds of all deaths from malignant neoplasms other than leukemia were certified to cancer of the digestive organs and peritoneum, 78% in males, 56 % in females. These sites are responsible for much of the dose-specific variation observed for cancers of all forms except leukemia, and especially for the influence of Hiroshima females. On the whole, the relationship to dose seems weaker for cancer of the GI tract than for all sites combined (Table XII) (Table IV) . However, the distance analysis for 1950-1954 (Table XIII) Table IV 
Cancer of Respiratory System (ICD # 160-165)
There were 203 deaths coded to cancer of the respiratory system over the 16-year period, 145 being attributed to cancer of the bronchus, trachea, and lung (ICD # 162-163). Table XIV gives the O/E ratios by sex and city corresponding to the panel in Table IV . Although in the overall tests for heterogeneity in Table  IV the analysis by distance groups is most relevant (Table XV) . over 20 ATB contribute to the excess mortality in 1950-1954, an unexplained, somewhat isolated, observation.
Women of all ages which still remains

Cancer of Other and Unspecified Sites (ICD # 190-199)
There were 126 deaths from cancer of other and unspecified sites. Although the O/E ratio does increase with dose the numbers of deaths are too small to achieve statistical significance (Table IV) (Table XVI) . This large class of diseases accounts for 380 deaths among the A-bomb survivors (Table IV) (Table XVII) , but the numbers of deaths in the high-dose groups are quite small.
Diseases of Blood and Blood-Forming Organs (ICD / 290-299)
During the 16-year period there were 51 deaths coded to the anemias and 33 to other diseases of the hematopoietic system. The rather strong association with T-65 dose seen in Table IV pertains to all four time periods and to all four city-sex groups, although the Nagasaki deaths are few. Unlike deaths from leukemia, which declined from 40 in 1950-1954 to 19 in 1962-1966, these deaths increased from 16 to 25 . Their older age distribution ATB is also not characteristic of the leukemia cases. In earlier reports (1-3) some excess of deaths from anemia was noted in the proximally exposed, and it was indicated that occasional deaths from leukemia may be erroneously certified to the anemias and other diseases of the hematopoietic system. Since all diagnoses of this class are subject to review by hematologists and pathologists working on the leukemia screening program at ABCC (25), it is now possible to examine this material more critically. It was found that 60 of the 84 cases had been investigated in detail, and seven considered to be leukemia. Elimination of these seven cases weakens, without eliminating, the variation with dose seen in Table IV . Its meaning, however, remains unclear, for numerous diagnoses are involved and differentiation is difficult.
Diseases of the Nervous System and Sense Organs (ICD # 330-398)
There were 2,840 deaths coded to diseases of the nervous system, distributed among the ICD rubrics as follows: The cerebrovascular diseases are not frequently designated the principal diagnosis at autopsy, as ABCC pathologists give preference to hypertension and generalized arteriosclerosis, but quite often ICD # 330-334 are listed among the associated diagnoses when they fail of selection as the primary autopsy diagnosis. For these reasons, the analysis was conducted with primary emphasis on the class as a whole (Table  IV) , but additional tables were run for the 2,690 deaths coded to the cerebrovascular diseases per se, and for the 602 deaths in 1961-1966 with autopsy diagnoses of hemorrhage, embolism, or thrombosis of the central nervous system. In none of these analyses, which made use of both T-65 dose and distance, and extended to separate examination of the four-year time segments, the city-sex groups, and age ATB cohorts, was even suggestive evidence of association with ionizing radiation seen.
Diseases of the Circulatory System
In addition to the 2,690 deaths attributed to cerebrovascular diseases, there were 1,587 coded to cardiovascular and other circulatory diseases, as these were classified in the 1955 revision of the ICD: Separate and complete statistical analyses were made on all 1,587 deaths (Table  IV) , and on the four subgroups noted above with asterisks (*). None of these identified any general evidence of relationship with ionizing radiation, or any subgroup for which such a relationship seemed likely. In addition, 1961-1966 autopsy diagnoses of rheumatic fever and rheumatic heart disease (76 cases), and of endocarditis and myocardial degeneration (238 cases), were analyzed in relation to T-65 dose without uncovering variation outside the usual bounds of chance.
ICD rubric Deaths
Diseases of the Respiratory System (ICD # 480-527)
There were 352 deaths attributed to diseases of the respiratory system, 282 from influenza, pneumonia, and bronchitis, and 70 from other respiratory diseases. Examination of this material by city, sex, age ATB, and interval of death, disclosed no important suggestion of any relationship to either T-65 dose or distance from hypocenter ATB. This was true of all 352 deaths taken as a whole (Table  IV) , and of the 282 deaths from influenza, pneumonia, and bronchitis taken as a separate class. 
Diseases of the Digestive System (ICD / 530-587)
Deaths from diseases of the digestive system number 1,119 among the A-bomb survivors during the entire 16-year period (Table IV) (Table  IV) , and in full detail as to age ATB, calendar time, city, and sex, and with both distance and dose used as the measure of exposure to ionizing radiation. There is a real excess of such deaths among the most heavily exposed survivors during 1950-1954 (Table XVIII) Table IV by T-65 dose. 1950-1954, the most proximally exposed suffered excess mortality (relative to the Whether the higher risk of death from ill-defined causes among those with the greatest exposure to radiation is attributable to radiation per se, or to some other aspect of the overall catastrophic experience, the intensity of which also depends on distance ATB, is simply unknown. It is possible that those nearer the hypocenter had less access to medical care before death in the 1950-1954 period, and thus were more likely to have vague entries on their death certificates. It should be recalled that the earlier analyses of all natural causes except leukemia revealed a real excess of mortality in distance group A during 1950-1954 (241 deaths observed vs. 212 expected), which makes it unlikely that the excess in mortality from ill-defined conditions is no more than a reflection of the quality of the death certification, and merely balances out deficits in mortality coded to more specific causes.
All Natural Causes Except Malignant Neoplasms
Apart from the findings with respect to diseases of blood and blood-forming organs, the analyses have identified only leukemia and other forms of cancer as causes of death that depend upon the amount of ionizing radiation received by A-bomb survivors. There can be no question, at this time, about the fact of the leukemogenic effect. Any uncertainties relate only to its duration and to the details of dose response as a function of the quality of radiation, time, and, perhaps, certain host factors. The evidence given here for a general carcinogenic effect, in contrast, is notably weak, and will need to be supplemented by later observations before it can be fully credited. And yet this is not the first important body of human data to suggest a general carcinogenic effect (8, 9) and, for the thyroid at least, ABCC data already seem adequately cogent (10). For these reasons, we have chosen to remove, from the set of deaths from all natural causes, those attributed to malignant neoplasms (ICD ^ 140-205) in making an empirical test of the hypothesis that ionizing radiation causes nonspecific aging in man (32). This subject has been studied on a small scale at ABCC by Hollingsworth and others (33) at the level of clinical observation and physiological measurement without uncovering evidence that A-bomb survivors who received the larger amounts of radiation seem older than others, born in the same year, who received less radiation from the bombs.
Mortality from all natural causes except malignant neoplasms was studied in the same way as in the foregoing cause-specific analyses. A summary of the 16-year mortality appears in Table IV . Since the hypothesis of accelerated aging may be confirmed by the experience of the A-bomb survivors only after the passage of some years, and on the part of only some age-ATB cohorts, the analysis has been extended to age-specific comparisons within each four-year interval. Mortality from these causes seems not to have been accelerated in the survivors who received the greatest amounts of radiation (Fig. 2) . The proportions dying within individual age-ATB cohorts of specified dose, and for individual four-year periods, are often highly unstable in the sampling sense, but the statistical tests performed on this material support the graphic appearance of the data, namely, that none of the age groups of highest dose had suffered any general increase in mortality by 1966. The 1962-1966 data for all exposure groups are given in Table XIX A breakdown by age shows that the excess is confined to ages 40-59 ATB, which is consistent with the cause-of-death differences above, i.e., diabetes, cerebrovascular disease, and heart disease. For the highest dose group, exposed to 180+ rads, observed and expected deaths for these three main groups of causes are: In the separate analyses of mortality from these groups of causes of death, no association with radiation was found, and the discrepancies seen here are too focal with respect to both cause and dose group to qualify as evidence for radiation-induced, nonspecific, aging. Nevertheless, it remains possible that the youngest victims of the bomb will in time manifest an abnormal mortality pattern; by 1966 those under 10 ATB were at most 31 years of age. For most of the older groups ATB, however, the experience through 1966 should be definitive enough, and all the mortality effects seen in these groups seem better explained in terms of disease-specific effects of ionizing radiation. These findings stand in contrast to those of Seltser and Sartwell on U.S. radiologists (9), who differ from the A-bomb survivors in that their exposure was not acute, but chronic, and their ranks were never sharply reduced by acute mortality. In the end, the relation between distance ATB and mortality Apart from the findings with respect to leukemia and other malignant neoplasms, and perhaps also diseases of blood and blood-forming organs, there is very little variation in mortality in relation to radiation dose, especially after 1950-1954. Perhaps most striking is the fact that the examination of mortality from all natural causes except malignant neoplasms provides no support for the hypothesis that ionizing radiation accelerates aging in man in some general, nonspecific, fashion.
Systematic comparisons of the A-bomb survivors with those not in the city ATB have also been made (26), but are not described here because they throw no further light on the probable effects of radiation or on their magnitude.
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